|
Real-time
Euronext Paris
05:25:30 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 0.4525 EUR | -4.13% |
|
-10.75% | +15.73% |
| 09-08 | EARNINGS AND TRADING: Acuity eyes 'breakeven' as loss narrows | AN |
| 09-08 | Novacyt S.A. Launches IVDR-Certified Yourgene Insight DPYD Assay | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Medical Devices
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 38.53M | - | - | |||
| 74.41B | |||||
| 59.26B | |||||
| 47.14B | |||||
| 42.91B | |||||
| 44.13B | - | - | - | - | - |
- Stock Market
- Stocks
- ALNOV Stock
- Charts Novacyt
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
